Clinical trials
Oncology clinical trials
Below are recruiting oncology clinical trials, each written for real people, not researchers. We’re tracking 783 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07295236Recruiting
Vacuum therapy for a leak after stomach surgery
This trial tests whether a treatment called endoscopic vacuum therapy can help heal a small leak that can happen after stomach removal surgery. If you are stable and the leak is small, this treatment may help you avoid more surgery.
KyivAges 18–90 - NCT07294040Recruiting
Low blood pressure after anesthesia in older cancer surgery patients
This study looks at what causes low blood pressure after anesthesia starts in older patients with cancer who are having surgery. It may help doctors prevent complications.
Ankara, AnkaraAges 65 years+ - NCT07295535Recruiting
Nasal immune responses to respiratory viruses in healthy and immunocompromised people
This study looks at how the nose's immune system responds to common respiratory viruses in both healthy people and those with weakened immune systems. It aims to understand how long these responses last.
Pavia, PaviaAges 18–90 - NCT07293247RecruitingPhase 2
Targeted radiation after lung cancer surgery
This trial tests if targeted radiation after surgery can help people with non-small cell lung cancer who still have cancer in their lymph nodes after chemotherapy. Participants will have had surgery and chemotherapy before starting radiation.
Jonesboro, ArkansasAges 18 years+ - NCT07288112RecruitingPhase 1/Phase 2
Immunotherapy using your own cells for advanced melanoma
This study tests an experimental treatment made from your own immune cells. The cells are collected, trained in the lab to recognize your melanoma, and then injected near your lymph nodes to help your immune system fight the cancer. This is for people whose melanoma has not responded to standard immunotherapy.
Birmingham, AlabamaAges 18 years+ - NCT06879938Recruiting
Hyaluronic Acid and Oxygen Therapy for Menopause Symptoms
This trial tests a combination of a vaginal gel (hyaluronic acid) and a special oxygen device for women experiencing vaginal dryness and discomfort due to menopause, including those with a history of breast cancer. It aims to see if this treatment can improve symptoms better than standard care.
Pavia, PaviaAges 18 years+ - NCT06717243Recruiting
Study on gene markers in lung cancer for treatment resistance
This study looks at genetic markers in two types of lung cancer (small cell and large cell neuroendocrine) to understand why some tumors stop responding to a standard treatment that combines chemotherapy with immunotherapy. If you have one of these cancers and are about to start this treatment, you may be able to join.
New York, New YorkAges 18–85 - NCT07284030Recruiting
Psychoeducation and well-being after breast cancer
This study tests an online program to help breast cancer survivors feel better. It focuses on education and support for emotional well-being after treatment.
IstanbulAges 18–65 - NCT07282158Recruiting
Coping help for ovarian cancer care providers
This trial tests a program to help doctors, nurses, and other clinicians who care for ovarian cancer patients manage burnout and stress. It aims to see if the adapted coping intervention improves well-being.
Seattle, WashingtonAges 18 years+ - NCT07283939Recruiting
Testing a tool to adjust chemo doses and reduce treatment delays
This trial tests a computer algorithm called PAGODA that helps doctors adjust chemotherapy doses for people with gastrointestinal cancers. The goal is to prevent unplanned treatment delays while keeping the treatment effective.
Fairbanks, AlaskaAges 18 years+ - NCT07279571Recruiting
AI chatbot education for gynecologic cancer patients
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
Los Angeles, CaliforniaAges 18 years+ - NCT07281820Recruiting
Using patient feedback to improve cancer care visits
This study aims to help doctors use patient-reported information to make follow-up visits more focused on what matters to you. It tests a new way of integrating your feedback into routine cancer care.
Vejle, Region SyddanmarkAges Any age - NCT06883201Recruiting
Blood management in breast cancer surgery
This trial tests a blood management approach for breast cancer patients with low iron or hemoglobin who are having surgery. It aims to improve recovery by treating anemia before and after surgery.
RomeAges 18 years+ - NCT05867966Recruiting
Testing a hypnosis-based program for symptom clusters in cancer
This trial studies whether a hypnosis-based approach can help reduce a selected set of troubling symptoms in people who have finished treatment for certain early-stage (non-metastatic) cancers. It aims to understand which symptom patterns improve and how well the intervention works.
LiègeAges 18 years+ - NCT07274579Enrolling by invitation
AI tool for gastric cancer protein testing
This trial tests an artificial intelligence model that helps doctors interpret a specific protein test (CLDN18.2) in stomach cancer tissue samples. It may help guide future treatment decisions.
Guangzhou, GuangdongAges 18 years+ - NCT07278726Recruiting
Targeted removal of only suspicious lymph nodes for early breast cancer
This trial is testing a targeted surgical approach to remove only the suspicious lymph nodes under the arm for people with early-stage, hormone receptor positive, HER2 negative breast cancer. The goal is to see if this less extensive surgery is safe and effective when there is limited lymph node involvement.
Bologna, ItalyAges 18–90 - NCT05776342Recruiting
Markers study for treatment response in pancreatic cancer
This study looks at tumor “markers” (tests on cancer tissue or related information) to understand how you may respond to first-line treatment for pancreatic cancer. Your results may help doctors better predict which treatments work best for different people.
BesançonAges 18 years+ - NCT07268378Enrolling by invitation
Supervision for oncology clinicians by psycho-oncologists
This trial studies whether supervision by a psycho-oncologist (a mental health expert in cancer care) helps doctors and nurses who work in oncology or hematology. It aims to support their well-being and communication skills.
Lausanne, Canton of VaudAges Any age - NCT06888843RecruitingPhase 2
Chemotherapy for colorectal cancer in patients 70+
This trial tests two chemotherapy drugs, capecitabine alone or with oxaliplatin, in people aged 70 or older after surgery for stage III colorectal cancer. The goal is to find out which treatment works better to prevent cancer from coming back.
Nizhny NovgorodAges 70–90 - NCT07258407RecruitingPhase 1/Phase 2
TD001 for men with PSMA-positive metastatic prostate cancer
This trial tests a new drug, TD001, in men whose prostate cancer has spread and is no longer responding to standard hormone therapy. It aims to see if TD001 is safe and effective against tumors that show a specific marker called PSMA.
New Haven, ConnecticutAges 18 years+ - NCT06755554RecruitingPhase 3
Green dye to guide lymph node removal in stomach cancer surgery
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
KyivAges 18 years+ - NCT06895291Recruiting
Whole body MRI for cancer patients
This study uses whole-body MRI scans to see if they help monitor or diagnose cancer better. It may be an option if your doctor has already recommended this type of scan.
Bologna, BOAges 18 years+ - NCT07258680Enrolling by invitationPhase 3
Testing brentuximab and etoposide for T-cell lymphoma
This trial tests whether adding the drugs brentuximab and etoposide to standard chemotherapy improves treatment for people newly diagnosed with T-cell lymphoma. It aims to find a more effective first treatment option.
Ages 18–70 - NCT07256210RecruitingPhase 2
Donor NK cells to prevent leukemia return after stem cell transplant
This trial tests whether giving donor natural killer (NK) cells after a stem cell transplant can help prevent leukemia from coming back. It is for people aged 14-25 with certain hard-to-treat leukemias who are already getting a stem cell transplant from a related donor.
MoscowAges 1 month–25 years
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for oncology?
- Yes. Clin2 currently lists 783 recruiting oncology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a oncology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a oncology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.